Home Details
| Official Symbol of Gene | CD33 |
| Species | Homo sapiens |
| Entrez Gene ID | 945 |
| Official Full Name | CD33 molecule |
| Also known as | p67; SIGLEC3; SIGLEC-3 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000105383 MIM:159590; AllianceGenome:HGNC:1659 |
| Map Location | 19q13.41 |
| Variation Type | SNP |
| refSNP ID | rs3865444 |
| Detected Sample | Blood |
| Sample Detail | N/A |
| Detected Method | TaqMan |
| Disease | MS |
| Disease subtype | N/A |
| Population | Greece |
| Sample Size | 1396 MS cases and 400 healthy controls |
| Pubmed ID | 33198164 |
| Year | 2020 |
| Title | Multiple Sclerosis: Shall We Target CD33? |
| Risk Type | Disease risk |
| Main Result | positive |
| Result | Therefore, we could assume that the CD33 rs3865444 GG genotype predisposes towards MS by increasing CD33 cell surface expression and decreasing the alternatively spliced CD33m variant, thus altering myeloid cells function. |
| Mechanism/Pathway | Therefore, we could assume that the CD33 rs3865444 GG genotype predisposes towards MS by increasing CD33 cell surface expression and decreasing the alternatively spliced CD33m variant, thus altering myeloid cells function. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.